Why Downtime Still Happens: Five HA Mistakes to Avoid 
Senteon and Compliance Scorecard Announce Strategic Partnership to Simplify Continuous Compliance TripleBlind Appoints Prat Moghe as CEO and Announces New AI Privacy Platform
Company’s patented AI Blinding™ technology delivers practical and proven solutions to unblock AI adoption in…
Exterro Revolutionizes Forensic Investigations with the Launch of FTK 8.0
Powerful new features such as automated artifact categorization, super timeline evidence view, and enhanced multimedia…
Exterro Revolutionizes Forensic Investigations with the Launch of FTK 8.0
Powerful new features such as automated artifact categorization, super timeline evidence view, and enhanced multimedia…
Equipment Hound Facilitates Critical Equipment Deal: Compressor for Oil and Gas Operations in Angola
VANCOUVER, British Columbia, Sept. 25, 2023 (GLOBE NEWSWIRE) — Interfield Global Software Inc. (NEO: IFSS)…
Equipment Hound Facilitates Critical Equipment Deal: Compressor for Oil and Gas Operations in Angola
VANCOUVER, British Columbia, Sept. 25, 2023 (GLOBE NEWSWIRE) — Interfield Global Software Inc. (NEO: IFSS)…
Cardinal Global Logistics Scales Customs Bureau with Descartes e-Customs™ Solution
LONDON, United Kingdom and ATLANTA, Sept. 25, 2023 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX)…
Micromem Update on Purchase Orders
Toronto, Ontario and New York, New York–(Newsfile Corp. – September 25, 2023) – Micromem Technologies…
Turnium Technology Group Results of Annual Meeting of Shareholders
Vancouver, Canada–(Newsfile Corp. – September 25, 2023) – Turnium Technology Group Inc. (TSXV: TTGI) (FSE:…
Schulte Roth & Zabel Continues Expansion of Investment Management Regulatory Capabilities With Addition of Michael Didiuk
NEW YORK–(BUSINESS WIRE)–Schulte Roth & Zabel is proud to announce the addition of Michael Didiuk…
Deveron Announces Private Placement of Convertible Debentures
Toronto, Ontario–(Newsfile Corp. – September 25, 2023) – Deveron Corp. (TSXV: FARM) (“Deveron” or the…
Label Foundation Joins Hands with LG Electronics for ‘Tracks’ Music Streaming Service
Tortola, British Virgin Islands–(Newsfile Corp. – September 25, 2023) – The Label Foundation recently announced…
SurgeGraph Announces Upcoming AI Image Generation Feature: Content Vision
In a newly uploaded video, SurgeGraph announces their upcoming feature called Content Vision, an advanced…
Mitsubishi Motors to Showcase a Fulfilling Mobility Lifestyle that Awakens Drivers’ Adventurous Spirit at the Japan Mobility Show 2023
TOKYO, Sep 25, 2023 – (JCN Newswire) – TOKYO, Sept 25, 2023 – (JCN Newswire)…
Forum Asset Management Launches Initiative in International Institutional Markets And Hires Andrew J. Kavouras to Spearhead Growth
TORONTO, ON / ACN Newswire / September 25, 2023 / Forum Asset Management Inc. collectively…
500 Global Brings Policy, Tech and Venture Capital Together for the Next Decade of Innovation
On October 5th, 2023 the UpNext Summit will bring policymakers, investors, asset allocators and thought…
Cloudflare Helps Companies Reduce Their IT Infrastructure’s Carbon Footprint By Up To 96% by Moving To The Cloud
New report finds that switching enterprise network services from on premises devices to Cloudflare services…
FlexPoint Launches to Revolutionize Payments for Managed Service Providers and the Businesses They Serve
Announces launch of the FlexPoint payments platform supported by GreatAmerica Financial Services® to Offer a…
First Internet Bank Introduces Cash Flow Analysis to Do More Business™ Checking
FISHERS, Ind.–(BUSINESS WIRE)–#SBA–First Internet Bank’s Do More Business™ Checking enables entrepreneurs to accomplish more in…
Reviva Announces Last Patient Evaluated in Pivotal Phase 3 RECOVER Trial for Brilaroxazine in Schizophrenia
Topline data for RECOVER trial on track for October 2023 CUPERTINO, Calif., Sept. 25, 2023…
EPKINLYTM (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare as the First Bispecific Antibody to Treat Adults Patients with Certain Types of Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Media Release Subcutaneous EPKINLYTM (epcoritamab) is the first and only bispecific antibody approved in Japan…